Clinical Trials in San Francisco

Showing 8341-8360 of 9,883 trials

Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1

NCT00993148

The objective of this study is to evaluate the safety and efficacy of a novel combination antiretroviral therapy regimen consisting of maraviroc plus darunavir/ritonavir in treatment-naive patients infected with R5-tropic HIV-1. The hypothesis is that in treatment-naive subjects infected with R5-tropic HIV-1, combination antiretroviral therapy with maraviroc plus darunavir/ritonavir is well tolerated and efficacious.

HIV-1 InfectionHIV Infections

Northwestern University25 participantsStarted May 2010

San Francisco, California, United States • Miami, Florida, United States • Chicago, Illinois, United States +2 more locations

COMPLETEDNA< 1 mile

Valproic Acid in Treating Patients With Kaposi's Sarcoma

NCT00075777

RATIONALE: Valproic acid may help stop the growth of Kaposi's sarcoma cells by blocking the enzymes necessary for tumor cell growth. PURPOSE: This clinical trial is studying valproic acid in treating patients with HIV-related Kaposi's sarcoma.

Sarcoma

AIDS Malignancy Consortium19 participantsStarted Feb 2005

Los Angeles, California, United States • San Diego, California, United States • San Francisco, California, United States +10 more locations

Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1

Valproic Acid in Treating Patients With Kaposi's Sarcoma

Find Trials by Condition in San Francisco

Study of OraVerse® for Safety and Efficacy in Pediatric Dental Patients

Study of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate Cancer

Breast Cancer Risk Reduction: A Patient Doctor Intervention

131 I-MIBG in Treating Patients With Refractory or Relapsed Neuroblastoma

STARZ-TX2 Clinical Study: Study of Thoracic Aortic Aneurysm Repair With the Zenith TX2 Endovascular Graft

Study of an Oral Cdk Inhibitor Administered With an Oral BRAF Inhibitor in Patients With Advanced or Inoperable Malignant Melanoma With BRAF Mutation

MsFLASH-02: Interventions for Relief of Menopausal Symptoms: A 3-by-2 Factorial Design Examining Yoga, Exercise, and Omega-3 Supplementation

Evaluation of the Safety Use of the InsuPatch Device in Daily Life Conditions

Evaluation of the Effect of the InsuPatch Device on Insulin Pharmacokinetics in Clamp Studies

Safety and Efficacy Study to Evaluate Proellex in the Treatment of Premenopausal Women With Symptomatic Endometriosis

Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer

The ELEGANT Trial: Elevate Transvaginal Mesh vs. Anterior Colporrhaphy

Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer

Study of Clevidipine Assessing Its Preoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-1)

GAUSS: A Study of Obinutuzumab (RO5072759) in Patients With Indolent Non-Hodgkin's Lymphoma

A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder

A Study of the Efficacy and Safety of Imatinib Mesylate in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing C-kit Gene

Study Evaluating Rebif, Copaxone, and Tysabri for Active Multiple Sclerosis